dc.contributor.author | Kramer, Tilmann | |
dc.contributor.author | Ventovuori, Ville | |
dc.contributor.author | Heinonen, Ari | |
dc.contributor.author | Parkkari, Jari | |
dc.contributor.author | Korhonen, Marko T | |
dc.contributor.author | Rovio, Anja | |
dc.contributor.author | Hoenemann, Jan-Niklas | |
dc.contributor.author | Möstl, Stefan | |
dc.contributor.author | Sies, Wolfram | |
dc.contributor.author | Kaiser-Stolz, Claudia | |
dc.contributor.author | Chilibeck, Philip | |
dc.contributor.author | Tanaka, Hirofumi | |
dc.contributor.author | Kramer, Mira | |
dc.contributor.author | Rittweger, Joern | |
dc.contributor.author | Hautala, Arto J | |
dc.date.accessioned | 2024-09-04T10:08:05Z | |
dc.date.available | 2024-09-04T10:08:05Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Kramer, T., Ventovuori, V., Heinonen, A., Parkkari, J., Korhonen, M. T., Rovio, A., Hoenemann, J.-N., Möstl, S., Sies, W., Kaiser-Stolz, C., Chilibeck, P., Tanaka, H., Kramer, M., Rittweger, J., & Hautala, A. J. (2024). Prevalence of electrocardiographic markers associated with myocardial fibrosis in masters athletes : a cohort study. <i>BMJ Open Sport & Exercise Medicine</i>, <i>10</i>(3), e001988. <a href="https://doi.org/10.1136/bmjsem-2024-001988" target="_blank">https://doi.org/10.1136/bmjsem-2024-001988</a> | |
dc.identifier.other | CONVID_242548683 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/96923 | |
dc.description.abstract | Objectives Myocardial fibrosis (MF) is associated with an increased predisposition to adverse cardiac events. The accumulation of high-volume and high-intensity exercise over an extended duration potentially increases the risk of MF. Specific electrocardiographic markers have been correlated with the presence of MF. This study assessed the prevalence of MF-related electrocardiographic markers in a Track and Field Master Athletics Cohort (TaFMAC).
Methods Twelve-lead resting electrocardiograms (ECGs) were conducted on 155 athletes (90 males and 65 females) participating in the World Masters Athletics 2022. The ECG markers associated with MF, including pathological Q waves, inverted T waves, fragmented QRS complex, and prolonged QRS complex, were compared among different athletic specialities (endurance athletes n=51, sprinters n=69 and strength and power n=35).
Results Overall, 71 instances of MF-related markers were identified from 155 ECG recordings (46%). Fragmented QRS emerged as the most common marker, with a prevalence of 29% in endurance and strength and power athletes, and 35% in sprinters. No significant group differences were observed in the prevalence of MF markers, whether analysed collectively (p=0.467) or individually (pathological Q waves p=0.367, inverted T waves p=0.309, fragmented QRS complex p=0.747 and prolonged QRS complex p=0.132).
Conclusions The prevalence of MF markers, as determined by resting ECG, was evident in nearly half of masters athletes, irrespective of sex and sporting specialisation. These findings suggest resting ECG as a promising non-invasive method for the early identification of MF in athlete’s hearts. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | BMJ | |
dc.relation.ispartofseries | BMJ Open Sport & Exercise Medicine | |
dc.rights | CC BY-NC 4.0 | |
dc.title | Prevalence of electrocardiographic markers associated with myocardial fibrosis in masters athletes : a cohort study | |
dc.type | article | |
dc.identifier.urn | URN:NBN:fi:jyu-202409045810 | |
dc.contributor.laitos | Liikuntatieteellinen tiedekunta | fi |
dc.contributor.laitos | Faculty of Sport and Health Sciences | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.format.pagerange | e001988 | |
dc.relation.issn | 2055-7647 | |
dc.relation.numberinseries | 3 | |
dc.relation.volume | 10 | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © Author(s) (or their employer(s)) 2024 | |
dc.rights.accesslevel | openAccess | fi |
dc.subject.yso | yleisurheilu | |
dc.subject.yso | EKG | |
dc.subject.yso | urheilu | |
dc.subject.yso | urheilijat | |
dc.subject.yso | harjoittelu | |
dc.subject.yso | sydäntaudit | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p935 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p20204 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p965 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p3315 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p26412 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p2710 | |
dc.rights.url | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.relation.doi | 10.1136/bmjsem-2024-001988 | |
jyx.fundinginformation | The primary sponsor of the TaFMAC study was the German Aerospace Center (DLR) - Institute of Aerospace Medicine, Department of Muscle and Bone Metabolism, Linder Höhe, 51147 Cologne, Germany. No additional financial support was received for this study. TK was supported by the Cologne Clinician Scientist Program (CCSP)/Faculty of Medicine/University of Cologne, funded by the German Research Foundation (DFG, Project No. 413543196). | |
dc.type.okm | A1 | |